(Q37374229)

20 August 2017

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells (English)

1 reference

20 August 2017

0 references

0 references

1 reference

Angus G Jones

2

0 references

Timothy J McDonald

object named as

Timothy J McDonald

8

0 references

Andrew Tym Hattersley

object named as

Andrew T Hattersley

7

0 references

Richard A Oram

object named as

Richard A Oram

1

0 references

author name string

Rachel E J Besser

3

1 reference

20 August 2017

Bridget A Knight

4

1 reference

20 August 2017

Beverley M Shields

5

1 reference

20 August 2017

Richard J Brown

6

1 reference

20 August 2017

language of work or name

1 reference

1 January 2014

1 reference

20 August 2017

1 reference

20 August 2017

57

1 reference

20 August 2017

1

1 reference

20 August 2017

187-191

1 reference

Creative Commons Attribution 2.0 Generic

20 August 2017

start time

12 October 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Standardization of C-peptide measurements

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855529

Pathologic anatomy of the pancreas in juvenile diabetes mellitus

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24121625

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24121625

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

International comparison of C-peptide measurements

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24121625

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-013-3067-X

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

24121625

1 reference